KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Invested Capital: 2011-2025

Historic Return on Invested Capital for Regeneron Pharmaceuticals (REGN) over the last 12 years, with Sep 2025 value amounting to 0.11%.

  • Regeneron Pharmaceuticals' Return on Invested Capital fell 2.00% to 0.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11%, marking a year-over-year decrease of 2.00%. This contributed to the annual value of 0.13% for FY2024, which is 2.00% down from last year.
  • Per Regeneron Pharmaceuticals' latest filing, its Return on Invested Capital stood at 0.11% for Q3 2025, which was down 8.99% from 0.12% recorded in Q2 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Return on Invested Capital ranged from a high of 0.39% in Q4 2021 and a low of 0.11% during Q3 2025.
  • Its 3-year average for Return on Invested Capital is 0.14%, with a median of 0.13% in 2024.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first grew by 14bps in 2021, then declined by 21bps in 2022.
  • Quarterly analysis of 5 years shows Regeneron Pharmaceuticals' Return on Invested Capital stood at 0.39% in 2021, then fell by 21bps to 0.18% in 2022, then declined by 3bps to 0.14% in 2023, then declined by 2bps to 0.12% in 2024, then fell by 2bps to 0.11% in 2025.
  • Its Return on Invested Capital was 0.11% in Q3 2025, compared to 0.12% in Q2 2025 and 0.12% in Q1 2025.